New insights into the molecular mechanisms of anesthetic drugs on the central nervous system
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
While clinicians have administered general anesthetics to millions of patients over more than 170 years, the precise molecular events that cause loss of consciousness remain surprisingly incomplete in their characterization. This research examined receptor binding profiles, downstream signaling cascades, and neural network effects of eleven commonly used anesthetic agents through a combined in vitro electrophysiology and clinical biomarker investigation at two Polish university hospitals. A prospective translational cohort enrolled 178 adult patients undergoing elective surgery under general anesthesia at the Medical University of Warsaw and the Jagiellonian University Medical Centre in Krakow between May 2019 and November 2021. In vitro binding assays quantified agent-specific interaction scores across six receptor systems: GABA-A, NMDA, glycine, two-pore domain potassium channels, hyperpolarization-activated cyclic nucleotide-gated channels, and voltage-gated sodium channels. Clinical correlates included processed electroencephalography patterns, serum neurofilament light chain levels as markers of neuronal stress, and time to return of consciousness after anesthetic discontinuation. GABA-A receptor interactions accounted for 32.4% of all quantified molecular target engagement across the agent panel. A strong positive correlation emerged between GABA-A binding affinity and clinical anesthetic potency (r=0.87, p
Fields of Study & Subjects
Anesthesia and Sedative Agents
Anesthesia and Neurotoxicity Research
Neuroscience and Neuropharmacology Research
Publication details
- Journal / source
- International Journal of Anesthesiology Sciences
- Volume
- 8
- Issue
- 1
- Pages
- 13–19
- Publication date
- 1 January 2026
- Language
- EN